Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126274391 | 12627439 | 1 | I | 20160723 | 20160805 | 20160805 | EXP | E2B_00524208 | CA-HQ SPECIALTY-CA-2016INT000719 | INTERCHEM | 66.00 | YR | M | Y | 0.00000 | 20160805 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126274391 | 12627439 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | U | 201749 | ||||||||||
| 126274391 | 12627439 | 2 | SS | ENBREL | ETANERCEPT | 1 | UNK | U | 0 | ||||||||||
| 126274391 | 12627439 | 3 | SS | CELEBREX | CELECOXIB | 1 | UNK | U | 0 | ||||||||||
| 126274391 | 12627439 | 4 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG, (5 MG,2 IN 1 D) | U | 0 | 5 | MG | |||||||
| 126274391 | 12627439 | 5 | SS | NAPROSYN | NAPROXEN | 1 | UNK | U | 0 | ||||||||||
| 126274391 | 12627439 | 6 | C | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | Oral | 150 MG (75 MG,2 IN 1 D) | U | 0 | 75 | MG | |||||||
| 126274391 | 12627439 | 7 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126274391 | 12627439 | 1 | Rheumatoid arthritis |
| 126274391 | 12627439 | 2 | Rheumatoid arthritis |
| 126274391 | 12627439 | 3 | Arthritis |
| 126274391 | 12627439 | 4 | Rheumatoid arthritis |
| 126274391 | 12627439 | 5 | Product used for unknown indication |
| 126274391 | 12627439 | 6 | Product used for unknown indication |
| 126274391 | 12627439 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126274391 | 12627439 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126274391 | 12627439 | Abdominal pain upper | |
| 126274391 | 12627439 | Activities of daily living impaired | |
| 126274391 | 12627439 | Anxiety | |
| 126274391 | 12627439 | Aphthous ulcer | |
| 126274391 | 12627439 | Arthralgia | |
| 126274391 | 12627439 | Arthropathy | |
| 126274391 | 12627439 | Asthenia | |
| 126274391 | 12627439 | Bone pain | |
| 126274391 | 12627439 | Contraindicated product administered | |
| 126274391 | 12627439 | Decreased activity | |
| 126274391 | 12627439 | Depression | |
| 126274391 | 12627439 | Drug ineffective | |
| 126274391 | 12627439 | Dry mouth | |
| 126274391 | 12627439 | Erythema | |
| 126274391 | 12627439 | Fatigue | |
| 126274391 | 12627439 | Hernia | |
| 126274391 | 12627439 | Joint swelling | |
| 126274391 | 12627439 | Lip swelling | |
| 126274391 | 12627439 | Malaise | |
| 126274391 | 12627439 | Muscular weakness | |
| 126274391 | 12627439 | Musculoskeletal pain | |
| 126274391 | 12627439 | Myocardial infarction | |
| 126274391 | 12627439 | Nausea | |
| 126274391 | 12627439 | Nervousness | |
| 126274391 | 12627439 | Neuropathy peripheral | |
| 126274391 | 12627439 | Pain | |
| 126274391 | 12627439 | Pain in extremity | |
| 126274391 | 12627439 | Peripheral swelling | |
| 126274391 | 12627439 | Rash | |
| 126274391 | 12627439 | Rheumatoid arthritis | |
| 126274391 | 12627439 | Sleep disorder | |
| 126274391 | 12627439 | Swelling | |
| 126274391 | 12627439 | Tenderness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |